Sign in

CIK 0000748592 · Non-accelerated filer<br>Smaller reporting company

Ernexa Therapeutics Inc.

Sign in to watch
Ticker
ERNA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
311103425
Phone
(617) 798-6700
Business address
1035 CAMBRIDGE STREET, SUITE 18A, CAMBRIDGE, MA, 02141
Former names
Eterna Therapeutics Inc., Brooklyn ImmunoTherapeutics, Inc., NTN BUZZTIME INC, NTN COMMUNICATIONS INC

Securities

  • ERNA Common Stock Nasdaq
  • ERNAW Warrants Nasdaq
  1. 8-K Event Auditor change
  2. EFFECT Other Notice of Effectiveness
  3. 424B3 Offering Prospectus
  4. CORRESP Other Correspondence Between Filers and SEC Staff
  5. UPLOAD Other SEC-generated Letter
  6. 8-K Event Bylaws or fiscal year change
  7. SCHEDULE 13D/A Stake Beneficial Ownership Report
  8. 4 Open-market buy 10% owner bought 21,241,163 shares at $0.10 ($2,221,826)
  9. S-8 Other Securities Offered to Employees in Benefit Plans
  10. S-3 Offering Registration Statement
  11. 8-K Event Unregistered share sale · Other events
  12. 8-K Event Bylaws or fiscal year change · Shareholder vote results
  13. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  14. SCHEDULE 13G Stake Statement of Beneficial Ownership
  15. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  16. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  17. 10-Q Report Quarterly Report
  18. 4/A Open-market buy 10% owner bought 13,252,112 shares
  19. EFFECT Other Notice of Effectiveness
  20. 424B3 Offering Prospectus

Page 4 of 77 · 1,525 filings